Screening of drug metabolism by CE
- 29 November 2006
- journal article
- ce and-cec
- Published by Wiley in Electrophoresis
- Vol. 27 (23) , 4827-4835
Abstract
The use of CE for rapid assessment of metabolic stability of drugs with cytochrome P450 (CYP) enzymes, based on relative rates of reduced nicotinamide adenine dinucleotide phosphate (NADPH) consumption and nicotinamide adenine dinucleotide phosphate (NADP) production, was investigated. The separation conditions were as follows: capillary, 80.5 cm (75 µm id, 72 cm effective length for UV detection, 58 cm effective length for fluorescence detection); 25 mM sodium phosphate buffer (pH 8.8); 28 kV (80 µA) applied voltage; UV, 260 nm; fluorescence detection, excitation wavelength, 310 nm, emission wavelength, 418 nm; capillary temperature, 25°C. For UV detection, the incubation conditions were as follows: CYP3A4: 20 pmol/mL; NADPH: 1 mM; EDTA: 1 mM; concentration of the substrate: 5–10 times its reported literatureKm value; temperature: 37°C; incubation time: 15 min. For fluorescence detection, the concentrations were reduced to CYP3A4: 4 pmol/mL, NADPH: 20 µM, EDTA: 20 µM and substrate: 10 µM. Blank incubations were performed in the absence of substrate. Compared with the blank, significant differences were found for the consumption of NADPH and the production of NADP. The development of this assay system allows rapid assessment of metabolic stability relative to standard compounds, as well as potential identification of the major CYP involved in the metabolism. It would reduce the backlog of compounds that require LC/MS analysis, and thereby expedite the process of metabolic stability screening.Keywords
This publication has 25 references indexed in Scilit:
- Kinetic study of CYP3A4 activity on verapamil by capillary electrophoresisJournal of Pharmaceutical and Biomedical Analysis, 2005
- Kinetic study of cytochrome P450 3A4 activity on warfarin by capillary electrophoresis with fluorescence detectionJournal of Chromatography A, 2005
- Cytochrome P450 3A4 and P‐glycoprotein Expression in Human Small Intestinal Enterocytes and Hepatocytes: A Comparative Analysis in Paired Tissue SpecimensClinical Pharmacology & Therapeutics, 2004
- High‐throughput screening for stability and inhibitory activity of compounds toward cytochrome P450‐mediated metabolismJournal of Pharmaceutical Sciences, 2004
- Summary of information on human CYP enzymes: human P450 metabolism dataDrug Metabolism Reviews, 2002
- Cytochrome P4502001
- CYP3A4 drug interactions: correlation of 10 in vitro probe substratesBritish Journal of Clinical Pharmacology, 1999
- The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitorsEuropean Journal of Clinical Pharmacology, 1998
- Inhibition and induction of human cytochrome P450 (CYP) enzymesXenobiotica, 1998
- Membrane stabilizing, anti-oxidative interactions of propranolol and dexpropranolol with neutrophilsBiochemical Pharmacology, 1996